Comparative effectiveness of spacers for the delivery of extrafine veruss non-extrafine particle ICS in asthma

The objective of this study is to investigate the real life effectiveness of ICS delivery of Fluticasone Propionate (FP) and Qvar® (beclomethasone dipropionate HFA) by pMDI with spacer compared to pMDI alone.

Lead Investigator:
Professor David Price
Research Team:
Catherine Hutton
Victoria Carter
Annie Burden
Vicky Thomas
Kathryn Richardson
Muzammil Ali
Julie von Ziegenweidt
Alice Durieux
Status: Active Study
Support: Teva
Documents and Publications:
Final Publications
Additional Material

Leave a Reply

Your email address will not be published. Required fields are marked *